⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.

Official Title: A Multicenter, Open Label, Phase 1 Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INC280 Tablet Formulation With Food in Patients With cMET Dysregulated Advanced Solid Tumors.

Study ID: NCT02925104

Interventions

INC280

Study Description

Brief Summary: Dose escalation study to assess PK, safety and tolerability of INC280 when taken with food in patients with cMET dysregulated advanced solid tumors.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Indiana University Simon Cancer Center SC, Indianapolis, Indiana, United States

Novartis Investigative Site, Salzburg, , Austria

Novartis Investigative Site, Herlev, , Denmark

Novartis Investigative Site, Dresden, , Germany

Novartis Investigative Site, Mainz, , Germany

Novartis Investigative Site, Nijmegen, , Netherlands

Novartis Investigative Site, Malaga, Andalucia, Spain

Novartis Investigative Site, Santiago de Compostela, Galicia, Spain

Novartis Investigative Site, Barcelona, , Spain

Novartis Investigative Site, Madrid, , Spain

Novartis Investigative Site, Zaragoza, , Spain

Novartis Investigative Site, Goteborg, , Sweden

Novartis Investigative Site, Lund, , Sweden

Novartis Investigative Site, Stockholm, , Sweden

Novartis Investigative Site, Uppsala, , Sweden

Novartis Investigative Site, London, , United Kingdom

Novartis Investigative Site, Manchester, , United Kingdom

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: